• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Significantly elevated levels of plasma Programmed cell Death Ligand 1 (PDL-1) in wound fluids after colorectal cancer resection are a likely source of the persistently elevated plasma levels noted post-surgery.

Significantly elevated levels of plasma Programmed cell Death Ligand 1 (PDL-1) in wound fluids after colorectal cancer resection are a likely source of the persistently elevated plasma levels noted post-surgery.

Hmc Shantha Kumara, PhD1, Neil Mitra, MD1, Dasuni Niyagama Gamage, MD1, Carl S Winkler, MD1, Jaspreet K Sandhu, MD2, Xiaohong Yan, PhD1, Vesna Cekic, RN1, Nipa D Gandhi, MD1, Richard L Whelan, MD1. 1Mount Sinai West Hospital, Department of Surgery, New York,USA, 2Brookdale University Hospital & Medical Center, Department of Surgery,Brooklyn,New York,USA

Introduction: The protein B7 Homolog 1 (B7-H1), also named Programmed cell Death Ligand 1 (PDL-1), has proangiogenic and immunosupressive effects.  PDL-1 is a ligand for PD-1 which is expressed on activated T cells; PDL-1 binding renders activated lymphocytes senescent. Recently, it has been shown that PD-L1 plasma levels are elevated for 4 weeks after colorectal cancer (CRC) resection.  Added “free” PDL-1 in the blood may contribute to surgery-related immunosuppression by binding to PD-1 expressing circulating T-lymphocytes. The source of the plasma B7-H1 increase is unknown.  It has earlier been shown that plasma levels of VEGF and 11 other proangiogenic proteins are elevated x 3-5 weeks after surgery; the healing wounds may be the protein source since wound fluid (WF) levels are 3-40 x higher than blood levels.  This study’s purpose is to determine perioperative PDL-1 levels in blood and WF taken after CRC resection. 

Method: Consenting patients (pts) undergoing elective CRC enrolled in an IRB approved tissue /data bank in whom an intra-abdominal Jackson Pratt (JP) drain had been placed were studied. Demographic, Clinical and pathologic data were reviewed. Preoperative (preop) and post-operative (postop) blood and postop wound fluid (WF) samples were simultaneously collected at 1 or more postop time points, centrifuged and were stored at -80°C. Late samples (POD 7-20) were bundled into 7 day blocks and considered as single time points. PDL-1 levels were determined in duplicate via ELISA. The Wilcoxon and Mann and Whitney test were used for analysis (significance p<0.05). 

Results: Preop and 1 or more late plasma and WF samples from 23 CRC patients (colon 4, rectal 19; mean age 65.2± 11.4years) were analyzed.  The surgical methods were: laparoscopic, 13pts; hand assisted 7; open, 3. The mean incision length (cm) for the MIS and Open pts was 8.4±4.2 and 25.0±8.8, respectively.  The mean length of stay was 8.9± 5.3days.  Plasma PDL-1 levels on postop day (POD) 1, 3, and 7-13 were significantly higher than preop levels (p<0.001). Also, WF PDL-1 levels were significantly higher than the plasma levels at each postop time point (p=0.02-0.003).

Conclusion: PDL-1 WF levels were significantly higher than corresponding plasma levels (also elevated) for 3 weeks.  The highest PDL-1 levels were noted POD7-13.  A portion of the added PDL-1 in the plasma may originate in the healing wounds.  Elevated plasma PDL-1 may suppress TIL’s which may facilitate tumor growth.  Larger perioperative PDL-1 studies and studies investigating plasma PD-1 levels are warranted.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 93775

Program Number: P356

Presentation Session: Poster Session (Non CME)

Presentation Type: Poster

View this Poster

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search